SynthesisBlood advances2022

Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis.

Nazila Shafagati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.